Quanterix Corporation Selling, General and Administrative Expense
Quanterix Corporation (QTRX) reported Selling, General and Administrative Expense of $27.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-10
- Quanterix Corporation selling, general and administrative expense for the quarter ending 2026-06-30 was $27.35M, a 9.88% decline year-over-year.
- Quanterix Corporation selling, general and administrative expense for the quarter ending 2026-03-31 was $29.77M, a 4.49% decline year-over-year.
- Quanterix Corporation selling, general and administrative expense for the quarter ending 2025-12-31 was $35.14M, a 22.89% increase year-over-year.
- Quanterix Corporation selling, general and administrative expense for the quarter ending 2025-09-30 was $39.06M, a 70.52% increase year-over-year.
- Quanterix Corporation selling, general and administrative expense for fiscal 2025 was $138.01M, a 35.81% increase from fiscal 2024.
- Quanterix Corporation selling, general and administrative expense for fiscal 2024 was $101.62M, a 14.04% increase from fiscal 2023.
- Quanterix Corporation selling, general and administrative expense for fiscal 2023 was $89.11M, a 2.98% decline from fiscal 2022.
- Quanterix Corporation selling, general and administrative expense for fiscal 2022 was $91.85M, a 1.14% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $27.35M 10-Q · filed 2026-08-10 | $57.12M 10-Q · filed 2026-08-10 | $92.26M derived: sum of 3 quarters · filed 2026-08-10 | $131.32M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $29.77M 10-Q · filed 2026-05-06 | $64.91M derived: sum of 2 quarters · filed 2026-05-06 | $103.97M derived: sum of 3 quarters · filed 2026-05-06 | $134.32M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $35.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $74.20M derived: sum of 2 quarters · filed 2026-03-02 | $104.55M derived: sum of 3 quarters · filed 2026-08-10 | $138.01M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $39.06M 10-Q · filed 2025-11-10 | $69.41M derived: sum of 2 quarters · filed 2026-08-10 | $102.87M 10-Q · filed 2025-11-10 | $129.17M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $30.35M 10-Q · filed 2026-08-10 | $31.35M 10-Q · filed 2025-08-07 | $61.52M 10-Q · filed 2026-08-10 | $63.81M 10-Q · filed 2025-08-07 | $90.11M derived: sum of 3 quarters · filed 2026-08-10 | $113.02M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $31.17M 10-Q · filed 2026-05-06 | $32.46M 10-Q · filed 2025-05-12 | $59.76M derived: sum of 2 quarters · filed 2026-05-06 | $82.67M derived: sum of 3 quarters · filed 2026-05-06 | $106.75M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $28.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $51.50M derived: sum of 2 quarters · filed 2026-03-02 | $75.58M derived: sum of 3 quarters · filed 2026-03-02 | $101.62M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | $22.91M 10-Q · filed 2025-11-10 | $46.99M derived: sum of 2 quarters · filed 2025-11-10 | $73.03M 10-Q · filed 2025-11-10 | $96.46M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $24.08M 10-Q · filed 2025-08-07 | $24.14M 10-Q · filed 2024-08-08 | $50.12M 10-Q · filed 2025-08-07 | $50.13M 10-Q · filed 2024-08-08 | $73.56M derived: sum of 3 quarters · filed 2025-08-07 | $97.11M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $26.04M 10-Q · filed 2025-05-12 | $25.99M 10-Q · filed 2024-05-08 | $49.48M derived: sum of 2 quarters · filed 2025-05-12 | $73.03M derived: sum of 3 quarters · filed 2025-05-12 | $94.33M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $23.44M 10-K/A · filed 2024-12-26 | $46.99M derived: sum of 2 quarters · filed 2024-12-26 | $68.29M derived: sum of 3 quarters · filed 2024-12-26 | $89.11M 10-K · filed 2026-03-02 | $90.24M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $23.55M 10-K/A · filed 2024-12-26 | $23.59M 10-Q · filed 2023-11-08 | $44.86M derived: sum of 2 quarters · filed 2024-12-26 | $65.67M 10-K/A · filed 2024-12-26 | $66.07M 10-Q · filed 2023-11-08 | $84.06M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2023-06-30 | $21.31M 10-K/A · filed 2024-12-26 | $21.59M 10-Q · filed 2023-08-08 | $42.13M 10-K/A · filed 2024-12-26 | $42.47M 10-Q · filed 2023-08-08 | $60.51M derived: sum of 3 quarters · filed 2024-12-26 | $80.99M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2023-03-31 | $20.82M 10-K/A · filed 2024-12-26 | $20.88M 10-Q · filed 2023-05-09 | $39.20M derived: sum of 2 quarters · filed 2024-12-26 | $59.68M derived: sum of 3 quarters · filed 2024-12-26 | $87.50M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2022-12-31 | $18.39M 10-K/A · filed 2024-12-26 | $38.86M derived: sum of 2 quarters · filed 2024-12-26 | $66.68M derived: sum of 3 quarters · filed 2024-12-26 | $91.85M 10-K · filed 2025-03-17 | $92.00M 10-K · filed 2023-03-06 | |||
| 2022-09-30 | $20.48M 10-K/A · filed 2024-12-26 | $19.97M 10-Q · filed 2022-11-09 | $48.30M derived: sum of 2 quarters · filed 2024-12-26 | $73.47M 10-K/A · filed 2024-12-26 | $72.72M 10-Q · filed 2022-11-09 | $102.46M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-06-30 | $27.82M 10-K/A · filed 2024-12-26 | $27.05M 10-Q · filed 2022-08-08 | $52.99M 10-K/A · filed 2024-12-26 | $52.76M 10-Q · filed 2022-08-08 | $81.98M derived: sum of 3 quarters · filed 2024-12-26 | $105.65M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-03-31 | $25.17M 10-K/A · filed 2024-12-26 | $25.71M 10-Q · filed 2022-05-10 | $54.17M derived: sum of 2 quarters · filed 2024-12-26 | $77.84M derived: sum of 3 quarters · filed 2024-12-26 | $98.63M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2021-12-31 | $29.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | $52.67M derived: sum of 2 quarters · filed 2024-12-26 | $73.45M derived: sum of 3 quarters · filed 2024-12-26 | $92.91M 10-K/A · filed 2024-12-26 | $92.34M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $23.67M 10-Q · filed 2022-11-09 | $44.46M derived: sum of 2 quarters · filed 2022-11-09 | $63.91M 10-Q · filed 2022-11-09 | $82.68M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $20.79M 10-Q · filed 2022-08-08 | $40.24M 10-Q · filed 2022-08-08 | $59.01M derived: sum of 3 quarters · filed 2022-08-08 | $72.46M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $19.45M 10-Q · filed 2022-05-10 | $38.22M derived: sum of 2 quarters · filed 2022-05-10 | $51.67M derived: sum of 3 quarters · filed 2022-05-10 | $64.77M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $18.77M 10-K · filed 2021-03-05 | $32.22M derived: sum of 2 quarters · filed 2021-11-04 | $45.32M derived: sum of 3 quarters · filed 2021-11-04 | $59.59M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $13.45M 10-Q · filed 2021-11-04 | $26.55M derived: sum of 2 quarters · filed 2021-11-04 | $40.83M 10-Q · filed 2021-11-04 | $54.78M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $13.10M 10-Q · filed 2021-08-05 | $27.38M 10-Q · filed 2021-08-05 | $41.33M derived: sum of 3 quarters · filed 2021-08-05 | $54.68M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $14.27M 10-Q · filed 2021-05-06 | $28.23M derived: sum of 2 quarters · filed 2021-05-06 | $41.58M derived: sum of 3 quarters · filed 2021-05-06 | $55.01M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $13.95M 10-K · filed 2021-03-05 | $27.30M derived: sum of 2 quarters · filed 2021-03-05 | $40.73M derived: sum of 3 quarters · filed 2021-03-05 | $52.25M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $13.35M 10-K · filed 2021-03-05 | $26.78M derived: sum of 2 quarters · filed 2021-03-05 | $38.29M 10-Q · filed 2020-11-06 | $48.87M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-06-30 | $13.43M 10-K · filed 2021-03-05 | $24.94M 10-Q · filed 2020-08-04 | $35.52M derived: sum of 3 quarters · filed 2021-03-05 | $44.36M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-03-31 | $11.51M 10-K · filed 2021-03-05 | $22.09M derived: sum of 2 quarters · filed 2021-03-05 | $30.93M derived: sum of 3 quarters · filed 2021-03-05 | $38.51M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2018-12-31 | $10.58M 10-K · filed 2020-03-13 | $19.42M derived: sum of 2 quarters · filed 2020-03-13 | $27.00M derived: sum of 3 quarters · filed 2020-03-13 | $33.69M 10-K · filed 2021-03-05 | ||||
| 2018-09-30 | $8.85M 10-K · filed 2020-03-13 | $16.43M derived: sum of 2 quarters · filed 2020-03-13 | $23.12M 10-Q · filed 2019-11-08 | $29.16M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-06-30 | $7.58M 10-K · filed 2020-03-13 | $14.27M 10-Q · filed 2019-08-06 | $20.32M derived: sum of 3 quarters · filed 2020-03-13 | $25.05M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-03-31 | $6.69M 10-K · filed 2020-03-13 | $12.74M derived: sum of 2 quarters · filed 2020-03-13 | $17.47M derived: sum of 3 quarters · filed 2020-03-13 | $22.21M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2017-12-31 | $6.05M 10-K · filed 2019-03-18 | $10.78M derived: sum of 2 quarters · filed 2019-03-18 | $15.52M derived: sum of 3 quarters · filed 2019-03-18 | $19.69M 10-K · filed 2020-03-13 | ||||
| 2017-09-30 | $4.73M 10-K · filed 2019-03-18 | $9.47M derived: sum of 2 quarters · filed 2019-03-18 | $13.64M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $4.75M 10-K · filed 2019-03-18 | $8.91M 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | $4.17M 10-K · filed 2019-03-18 | |||||||
| 2016-12-31 | $12.47M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |